Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat low starting dose regimens in CKD stages 3–5 non-dialysis anemia
CTR20220016Phase 4Completed
- Sponsor
- Fapon Biopharma
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxadustat in anaemia, sponsored by Fapon Biopharma. Started Jan 2022; status: completed.
02
Drugs
roxadustat
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20220016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220016.